141666-92-4Relevant articles and documents
Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway
Chen, Lanmei,Wang, Jie,Cai, Xianhong,Chen, Suxiang,Zhang, Jingjing,Li, Baojun,Chen, Weigang,Guo, Xinhua,Luo, Hui,Chen, Jincan
, (2021/12/04)
Both ruthenium (Ru) and isoquinoline (IQ) compounds are regarded as potential anticancer drug candidates. Here, we report the synthesis and characterization of three novel cyclometalated Ru(II)-isoquinoline complexes: RuIQ-3, RuIQ-4, and RuIQ-5, and evalu
Synthesis, enzyme inhibitory kinetics mechanism and computational study of N-(4-methoxyphenethyl)-N-(substituted)- 4-methylbenzenesulfonamides as novel therapeutic agents for Alzheimer's disease
Abbasi, Muhammad Athar,Hassan, Mubashir,Aziz-ur-Rehman,Siddiqui, Sabahat Zahra,Ali Shah, Syed Adnan,Raza, Hussain,Seo, Sung Yum
, (2018/07/05)
The present study comprises the synthesis of a new series of sulfonamides derived from 4-methoxyphenethylamine (1). The synthesis was initiated by the reaction of 1 with 4-methylbenzenesulfonyl chloride (2) in aqueous sodium carbonate solution at pH 9 to
SUBSTITUTED ALKYL DIARYL DERIVATIVES, METHODS OF PREPARATION AND USES
-
Page/Page column 97, (2014/04/04)
Compounds according to Formula I are provided: and salts thereof, wherein Q1, Q2, R3, R4, X, and Y are as defined herein. Methods for preparing compounds of Formula I are also provided, as well as methods of tre